ES2168263T3 - Formulacion enteral de densidad calorica baja diseñada para reducir la diarrea en pacientes entubados. - Google Patents

Formulacion enteral de densidad calorica baja diseñada para reducir la diarrea en pacientes entubados.

Info

Publication number
ES2168263T3
ES2168263T3 ES93107543T ES93107543T ES2168263T3 ES 2168263 T3 ES2168263 T3 ES 2168263T3 ES 93107543 T ES93107543 T ES 93107543T ES 93107543 T ES93107543 T ES 93107543T ES 2168263 T3 ES2168263 T3 ES 2168263T3
Authority
ES
Spain
Prior art keywords
tubed
patients
less
caloric density
low caloric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93107543T
Other languages
English (en)
Inventor
David A Mark
Lance Stalker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25390987&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2168263(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of ES2168263T3 publication Critical patent/ES2168263T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/804—Low calorie, low sodium or hypoallergic

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

LA PRESENTE INVENCION PRESENTA UN PRODUCTO ENTERAL PARA PROPORCIONAR LOS REQUERIMIENTOS NUTRICIONALES A UN PACIENTE, QUE COMPRENDE: UN CONTENIDO CALORICO MENOR DE 1,00 KCAL/ML; UNA OSMOLARIDAD INFERIOR A 300 MOSM; Y UN CONTENIDO DE FIBRA SUPERIOR A 15 GMS/ML PREFERENTEMENTE. ADEMAS, LA PRESENTE INVENCION PRESENTA UN METODO PARA PROPORCIONAR NUTRICION A UN PACIENTE A TRAVES DE UN PRODUCTO ENTERAL ADMINISTRADO POR UN TUBO Y REDUCIR EL RIESGO DE QUE SE PRODUZCA UNA DIARREA, QUE CONSISTE EN LOS PASOS SIGUIENTES: PROPORCIONAR UN PRODUCTO ENTERAL ESTERIL, QUE NO HAGA FALTA DILUIR, Y QUE TENGA UNA OSMOLARIDAD MENOR DE 300 MOSM Y UN CONTENIDO CALORICO INFERIOR A 1,0 KCAL/ML, PERO QUE TENGA UN CONTENIDO DE FIBRA SUPERIOR A 15 GMS/LITRO; Y ADMINISTRAR ENTERALMENTE EL PRODUCTO A UN PACIENTE.
ES93107543T 1992-05-21 1993-05-10 Formulacion enteral de densidad calorica baja diseñada para reducir la diarrea en pacientes entubados. Expired - Lifetime ES2168263T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/887,361 US5229136A (en) 1992-05-21 1992-05-21 Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients

Publications (1)

Publication Number Publication Date
ES2168263T3 true ES2168263T3 (es) 2002-06-16

Family

ID=25390987

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93107543T Expired - Lifetime ES2168263T3 (es) 1992-05-21 1993-05-10 Formulacion enteral de densidad calorica baja diseñada para reducir la diarrea en pacientes entubados.

Country Status (10)

Country Link
US (1) US5229136A (es)
EP (1) EP0570791B1 (es)
JP (1) JP3644023B2 (es)
AT (1) ATE210387T1 (es)
AU (1) AU3851993A (es)
CA (1) CA2095889C (es)
DE (1) DE69331296T2 (es)
DK (1) DK0570791T3 (es)
ES (1) ES2168263T3 (es)
PT (1) PT570791E (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
EP0873116A1 (en) * 1994-02-25 1998-10-28 New England Deaconess Hospital Corporation Anti-inflammatory and infection protective effects of sesamin-based lignans
US5558897A (en) * 1994-04-05 1996-09-24 Goldman; Marc S. Milk composition containing fiber and method for making same
US5753295A (en) * 1994-04-05 1998-05-19 Goldman; Marc S. Non-dairy composition containing fiber and method for making same
US5447741A (en) * 1994-04-05 1995-09-05 Goldman; Marc S. Milk composition containing fiber and method for making same
EP0756828B2 (en) * 1995-08-04 2010-09-22 N.V. Nutricia Nutritional composition containing fibres
US5821217A (en) * 1995-10-27 1998-10-13 Beth Israel Deaconess Medical Center, Inc. Enteral formulation: low in fat and containing protein hydrolysates
JP3556757B2 (ja) * 1996-02-09 2004-08-25 森永乳業株式会社 吸収促進性糖類組成物
US5767815A (en) * 1996-06-20 1998-06-16 Andrew Corporation Antenna feedhorn with protective window
US5776463A (en) * 1997-02-19 1998-07-07 Arginteanu; Ronit Method of reducing stress and circulatory heart disease with freeze-dried borage petal extracts
NZ337780A (en) * 1997-03-13 2001-05-25 Abbott Lab Liquid nutritional formula containing hydrolysed protein and a fiber blend for management of infant diarrhea, colic and other maladies
US5849335A (en) * 1997-06-02 1998-12-15 Nestec S.A. Composition and method for providing glutamine
DE10261061A1 (de) * 2002-12-24 2004-07-15 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Diätetisches Lebensmittel zur positiven Beeinflussung der kardiovaskulären Gesundheit
DE102004040452A1 (de) * 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
GB0622582D0 (en) * 2006-11-13 2006-12-20 Biotec Pharmacon Asa Animal feeds and veterinary compositions
WO2009052106A2 (en) * 2007-10-14 2009-04-23 University Of Florida Research Foundation Inc. Formulation to improve gastrointestinal function
CA2749401C (en) * 2009-01-19 2016-07-26 Nutri Co., Ltd. Low-concentration nutritional composition
WO2011093693A1 (en) 2010-01-29 2011-08-04 N.V. Nutricia Liquid enteral nutritional composition suitable for tube feeding, minimizing lower and upper tract digestive conditions
JP6084159B2 (ja) * 2011-05-13 2017-02-22 株式会社明治 粘性を有する栄養組成物
US9522131B2 (en) 2013-01-11 2016-12-20 Wisconsin Alumni Research Foundation Tannin-containing gastrointestinal formulations and methods of use
KR101525948B1 (ko) * 2014-12-10 2015-06-05 주식회사 엔에스웰니스 캐롭 추출물을 유효성분으로 포함하는 남성 갱년기 예방 및 개선용 조성물
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
JP7412627B1 (ja) * 2023-08-14 2024-01-12 サントリーホールディングス株式会社 容器詰めの大豆成分含有飲料

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112123A (en) * 1976-07-21 1978-09-05 Beatrice Foods Co. Nutritionally balanced single food composition and method of production
ATE65406T1 (de) * 1985-01-29 1991-08-15 Abbott Lab Enterales hypoallergenisches ernaehrungsrezept.
US4670268A (en) * 1985-01-29 1987-06-02 Abbott Laboratories Enteral nutritional hypoallergenic formula
DE3564370D1 (en) * 1985-08-30 1988-09-22 Nestle Sa Dietetic product with depurating and antidiarrheal activity and process for its preparation
SE8601828D0 (sv) * 1986-04-21 1986-04-21 Novo Industri As Enteral diet product and agent for production thereof
US4921877A (en) * 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance

Also Published As

Publication number Publication date
CA2095889C (en) 2003-07-15
EP0570791B1 (en) 2001-12-12
DK0570791T3 (da) 2002-04-02
DE69331296T2 (de) 2002-06-13
US5229136A (en) 1993-07-20
ATE210387T1 (de) 2001-12-15
AU3851993A (en) 1993-11-25
DE69331296D1 (de) 2002-01-24
CA2095889A1 (en) 1993-11-22
EP0570791A2 (en) 1993-11-24
JP3644023B2 (ja) 2005-04-27
EP0570791A3 (en) 1995-03-29
JPH0656693A (ja) 1994-03-01
PT570791E (pt) 2002-05-31

Similar Documents

Publication Publication Date Title
AU3851993A (en) Low-caloric density enteral formulation designed to reduce diarrhea in tube-fed patients
US5661123A (en) Enteral composition for malabsorbing patients
US4981844A (en) Method to improve immune response and resistance to infection following surgery by diet composition
DE69806820T2 (de) Kaloriereiche ernährungszusammensetzung
US5723446A (en) Enteral formulation designed for optimized nutrient absorption and wound healing
MX9304468A (es) Producto nutritivo enteral para personas que tienen un daño neurologico.
ES2177716T3 (es) Nutricion para pacientes mayores.
AR015057A1 (es) Producto alimenticio liquido elemental, metodo para proveer nutricion a un paciente, proteinas apropiadas para la incorporacion a productos alimenticiosliquidos elementales, y metodo para mejorar el gusto de los productos alimenticios liquidos elementales
ES2081066T3 (es) Composiciones para uso dietetico y terapeutico que comprenden glucidos y sus aplicaciones.
DE69620291D1 (de) Nahrungszusammensetzungen in verschiedenen Formen
AU628662B2 (en) Dietary supplement and method of minimizing effects of infection through diet
IL106977A0 (en) Enteral nutritional product
GR3032548T3 (en) Nutrition for persons undergoing radiation therapy and/or chemotherapy.
DE68924429D1 (de) Diät zur besserem Ueberleben von Kranken mit Sepsis.
CA2508280C (en) An aseptically packaged, extensively hydrolyzed, liquid nutritional formula and method for making it
JPS6456623A (en) Iodine-containing emulsion
EP0696453A2 (en) Pediatric lipid emulsion
EP0564804A1 (en) Improved high protein liquid nutrition for patients with elevated wound healing requirements
NO308502B1 (no) Høykaloriholdig ernærings-løsning med lav osmolalitet, for parenteral tilførsel
Mohler et al. Issues in Contemporary Drug Delivery: Part V: Total Parenteral Nutrition
Driscoll Physicochemical stability of all-in-one mixtures inclinical setting
Wenderoth Aspects of the new eicosanoid-research.).
Kalinkina et al. The effect of a diet enriched with omega-3 polyunsaturated fatty acids on thrombocyte functional activity and on the blood lipid-apolipoprotein spectrum in newly occurring stenocardia
MX9803212A (es) Productos alimenticios no grasos y bajos en grasa con sabor mejorado.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 570791

Country of ref document: ES